Skip to main content

Blood Pressure Alterations in CML Patients Treated with Imatinib vs. Nilotinib : A Clinical Insight Cover

.blurhash-client-img { display: none !important; }

Blood Pressure Alterations in CML Patients Treated with Imatinib vs. Nilotinib : A Clinical Insight

Romanian Journal of Internal Medicine

By: Wardiyanti Anwar, Tutik Harjianti, Pendrik Tandean, Syakib Bakri, Faridin Hp and Andi Alfian Zainuddin

Open Access

|Apr 2026

Figures & tables

Articles in this issue

DOI: https://doi.org/10.2478/rjim-2026-0005 | Journal eISSN: 2501-062X | Journal ISSN: 1220-4749

Journal RSS Feed

Language: English

Submitted on: Feb 19, 2026

|

Published on: Apr 6, 2026

Published by: N.G. Lupu Internal Medicine Foundation

In partnership with: Paradigm Publishing Services

Publication frequency: 4 issues per year

Keywords:

Chronic Myeloid Leukemia (CML),

Tyrosine Kinase Inhibitors (TKIs),

Blood Pressure Changes,

Related subjects:

Clinical medicine,

Internal medicine,

Internal medicine, other,

Gastroenterology,

© 2026 Wardiyanti Anwar, Tutik Harjianti, Pendrik Tandean, Syakib Bakri, Faridin Hp, Andi Alfian Zainuddin, published by N.G. Lupu Internal Medicine Foundation
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.